Share Facebook Twitter LinkedIn Pinterest Email Dynavax projects HEPLISAV-B revenue of $305M-$325M for 2025 amid expanding hepatitis B market
Solar stocks crushed as Senate budget bill proposal keeps cuts to solar incentives (ENPH:NASDAQ)June 17, 2025